Local production of pharmaceuticals and health system strengthening in Africa

Summary of an Evidence Brief in preparation

Growing herbal medicines

Download the preliminary summary here

Pharmaceutical manufacturing in Sub-Saharan Africa (SSA) is – contrary to external perceptions – long established. African governments and other actors including the African Union Commission, NEPAD and the East African Community are actively promoting industrial development in pharmaceuticals, supported by UN and other international partners including BMZ. At the same time, low income SSA populations suffer inadequate health care undermined by poor access to medicines. In the context of SDG3 and international commitments to universal health coverage (UHC), international intervention finances large scale international procurement of medicines and supports health system strengthening.

In the full Evidence Brief – to be published here in June 2017 - Maureen Mackintosh, Julius Mugwagwa, Geoffrey Banda and Jires Tunguhole will present evidence from stakeholder interviews, data and literature for the actual and potential health and development benefits from creating stronger local and global linkages between these industrial and health agendas, and outline how this can be done.

May 2017

BMZ glossary

Close window


Share page